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In this issue of Immunity, Hou et al. (2008) describe the generation of mice that selectively lack the adaptor
protein MyD88 in dendritic cells (DCs). These mice demonstrate that the requirement for Toll-like receptor
(TLR) signaling in DCs is dependent on the physical form of the TLR ligand.The invention of tools represents one of
the most seminal advances in human his-
tory. The opening sequence of Arthur
C. Clarke and Stanley Kubrick’s 2001: A
Space Odyssey depicts the inspiration of
our hominid ancestors to invent their first
tools. Fast forward to 2008, and the pres-
ent issue of Immunity depicts the inspired
invention of yet another tool, by Hou et al.
(2008): one that promises a deeper under-
standing of the innate immune responses
to microbes.
A cardinal feature of the innate immune
system is its ability to ‘‘sense’’ or recog-
nize microbial stimuli and to elicit rapid-
acting defense mechanisms. The innate
immune system consists of a network of
interacting cell types including dendritic
cells (DCs), macrophages, endothelial
cells, epithelial cells, mast cells, natural
killer (NK) cells, and NK T cells. DCs play
a central role in sensing microbial stimuli,
in coordinating the responses of the other
innate immune cells, and in translating in-
nate immunity into adaptive immunity.
Innate sensing of microbial stimuli occurs
through the expression of so-called pat-
tern-recognition receptors (PRRs)—ex-
pressed by DCs and other cells—which
in effect serve as the ‘‘sentinels of the im-
mune system.’’ Toll-like receptors (TLRs)
consist of an evolutionarily conserved
family of some 11 receptors, each of
which senses different types of microbial
and viral stimuli (Beutler, 2004; Akira,
2006; Medzhitov, 2007).
A general paradigm that has emerged
over the years suggests that innate recog-
nition—directly via TLRs—of microbial or
viral stimuli that are expressed on and
in DCs results in the activation of DCs
and their stimulation of robust T cell
responses (Pulendran, 2005). TLR-medi-
ated activation of DCs is largely depen-
dent on MyD88, which is a key signaling
adaptor for almost all TLRs and playsa fundamental role in the activation of the
transcription factor NF-kB (Akira, 2006). In
most cases, MyD88-dependent activa-
tion of DCs activated by TLR ligands
results in the production of interleukin-12
(IL-12), which favors the development of
T helper 1 (Th1) cells. In addition to this
direct activation of DCs, microbial TLR
ligands can also activate other cell types
in the tissue to secrete inflammatory mol-
ecules, such as TNF, that can also acti-
vate DCs, indirectly (Diebold, 2008). The
relative importance of the ‘‘direct’’ versus
‘‘indirect’’ mechanism of DC activation is
poorly understood. In this issue, Hou
et al. (2008) describe an elegant genetic
approach to address this question.
Hou et al. (2008) selectively ablated the
Myd88 gene from DCs by first generating
a mouse with a conditional allele of the
mouse Myd88 gene, by introducing
LoxP sites on either side of exon 3 of
this gene. Then they crossed these mice
with mice carrying the CD11c-Cre trans-
gene (Caton et al., 2007) to delete the
Myd88 gene from DCs. The authors found
that over 94% of theMyd88 flox allele was
deleted in conventional DCs (cDCs), and
around 80% was deleted in plasmacytoid
DCs (pDCs). In contrast, there was no
substantial deletion of Myd88 in splenic
macrophages, neutrophils, or NK cells,
or in naive or activated CD4+ T cells.
The authors first examined the inflam-
matory response to TLR stimulation in
DC-MyD88-deleted mice. Intravenous in-
jection of CpG containing oligodeoxynu-
cleotide ODN1826, a TLR9 ligand that
solely signals through the MyD88-depen-
dent pathway, resulted in robust produc-
tion of IL-12p40 in splenic CD8a+ DCs
from wild-type mice, but this response
was ablated in the DC-MyD88-deleted
mice. Furthermore, the induction of sys-
temic IL-12, as measured by IL-12p70 in
the serum, was also completely ablatedImmunityin the DC-MyD88-deleted mice, demon-
strating that DCs are the chief producers
of IL-12 in response to TLR9 stimulation
in vivo. Consistent with this observation,
the amount of IL-12p40 mRNA induced
in total splenocytes 1 hr after injection
of ligands for TLR1-TLR2, TLR4, TLR5,
TLR7, or TLR9 was also greatly reduced.
In addition to these striking effects on
IL-12 production, there was also a diminu-
tion of the mRNA for other proinflamma-
tory cytokines such as IL-6, IL-23, TNF,
IL-1b, and IFN-b. Thus, these results
argue in favor of a major role for MyD88-
dependent TLR signaling, within DCs, in
the mediation of the early innate response
to various TLR ligands.
The authors then examined the innate
responses in DC-MyD88-deleted mice to
an aggregated form of TLR9 ligand, by en-
capsulating CpG DNA with a cationic
lipid, DOTAP. The rationale here was
that many natural TLR ligands exist in
complexed forms. Previous work sug-
gests that the response to CpG-DOTAP
is MyD88 and TLR9 dependent (Honda
et al., 2005). Injection of CpG-DOTAP re-
sulted in enhanced uptake by several
subsets of antigen-presenting cells, in-
cluding CD11b+ DCs, pDCs, macro-
phages, and monocytes. Unlike soluble
CpG, CpG-DOTAP induced IL-12p40
from both CD8a+ and CD11b+ DCs, and,
as expected, this was dependent on
MyD88 signaling in these cells. Further-
more, CpG-DOTAP induced mRNA for
IFN-b in pDCs, which was also largely de-
pendent on MyD88 signaling in these
cells. Interestingly, CpG-DOTAP also
induced TNF production in DCs and
a monocyte-like population, but the
response in monocytes was not impaired
in DC-MyD88-deleted mice. Further-
more, CpG-DOTAP-mediated induction
of mRNA encoding IL-23, IL-6, and TNF
in the spleens of DC-MyD88-deleted29, August 15, 2008 ª2008 Elsevier Inc. 173
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mice, although this attenuation was much
less striking than the attenuation ob-
served when soluble CpG was used.
Consistent with this more prominent phe-
notype in response to soluble CpG, induc-
tion of CD86 and CD40 on DCs in vivo was
much more severely compromised in DC-
MyD88-deleted mice when soluble CpG
rather than CpG-DOTAP was injected.
These data suggest that CpG-DOTAP
stimulated TLR9 in non-DCs more effi-
ciently that soluble CpG, thus revealing
the contextual nature of innate immune
recognition and function (Figure 1). Be-
cause DOTAP has been shown to deliver
molecules to the cytosol, and because
the cytosol is thought to contain addi-
tional non-TLR innate sensing mecha-
nisms (Takaoka et al., 2007), it is possible
that the synergistic activation of TLR9 and
these other receptors mediates stronger
responses in a given cell type.
Because IL-12 is a potent stimulus for
IFN-g production, the authors examined
the induction of IFN-g in splenocytes after
injection of CpG and observed that NK
cells and NK T cells were the chief cellular
sources of IFN-g, within a few hours
of soluble CpG DNA injection. In DC-
MyD88-deleted mice, this was abolished,
suggesting an essential role for TLR acti-
vation of DCs in mediating the early innate
response of NK and NK T cells to soluble
CpG DNA. Interestingly, there was only
a partial ablation of IFN-g production by
NK cells and NK T cells when CpG-
DOTAP was used, again demonstrating
that other cell types in addition to DCs re-
spond and mediate the effects of aggre-
gated CpG DNA.
Given these striking defects in the early
innate response, the authors evaluated
the nature of the adaptive immune
response in DC-MyD88-deleted mice
immunized with ovalbumin (OVA) plus sol-
uble CpG, or OVA plus CpG-DOTAP. The
expansion and survival of OVA-specific
CD4+ Th1 cells was strikingly reduced in
DC-MyD88-deleted mice when OVA and
soluble CpG were used as an immuno-
gen. In contrast, when CpG-DOTAP was
used, there was no impairment in the
OVA-specific CD4+ T cell response.
Figure 1. In Vivo MyD88-Dependent and -Independent Signaling in Response to Soluble
versus Aggregated TLR Ligand
In response to soluble TLR ligands, MyD88 function in DCs is indispensable for the initiation of the adaptive
immune response and for directing polarization to a Th1 cell response. Direct TLR stimulation through
MyD88 signaling triggers robust IL-12 production on CD8a+ DCs, which then induce IFN-g response in
NK and NKT cells. As a result, DCs are activated and a vigorous Th1 cell response is initiated. In response
to aggregated ligands, the spectrum of responding cell types is enlarged, including CD11b+ DCs and other
non-DC cell types. Activated DCs and non-DCs produce large amounts of cytokines, including IL-12, IL-6,
and TNF. In particular, robust type I IFNs are secreted by pDCs and synergize with proinflammatory
cytokines secreted by other types of DCs and non-DCs to induce a robust Th1 response. Therefore,
MyD88 function in both DCs and non-DC cell types make a prominent and redundant contribution to
the response to aggregated TLR ligands.
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was a very substantial reduction in the
OVA-specific total IgG antibody titers
and a profound drop in the Th1 cell-type
antibody isotypes IgG2b and IgG2c
when OVA and soluble CpG was used.
In contrast, there was little or no effect
when CpG-DOTAP was used. These re-
sults can be explained by the effects of
two phenomena observed in the study:
First, MyD88-deficient DCs fail to mature
to upregulate the expression of costimu-
latory molecules; second, the production
of inflammatory cytokines, especially
IL-12, by DCs was markedly reduced in
the absence of MyD88 signaling. Further-
more, the IFN-g production by NK and
NKT cells after TLR stimulation in the
DC-MyD88-deleted mice was abolished.
Thus, the MyD88 function in DCs is indis-
pensable for IFN-g response that initiates
Th1 cell polarization of antigen-stimulated
CD4+ T cells. Thus, Hou et al. (2008)
clearly demonstrated for the first time
the strong dependence of MyD88 func-
tion in DCs in response to soluble CpG
stimulation. In contrast, non-DC cell types
including macrophages and monocytes
were shown to be activated by CpG-DO-
TAP to produce inflammatory cytokines
and trigger IFN-g response, which was
not compromised in the DC-MyD88-
deleted mice.
These experiments provide evidence
that direct recognition of microbial stimuli
by TLR on DCs is essential for the initia-
tion of the CD4+ T helper cell responses
and polarization toward the Th1 cell path-
way. That direct TLR-mediated activation
of DCs is essential for Th cell polarization
is consistent with an earlier report by
Spo¨rri and Reis e Sousa, 2005, which
demonstrated that direct TLR stimulation
in DCs was necessary to license DCs to
drive full activation and Th cell differentia-
tion, whereas indirect DC activation by
inflammatory mediators alone was insuffi-
cient to drive full DC maturation and
the acquisition of the ability to polarize
T helper cells. However, the two studies
differ in that the previous study showed
that indirect DC maturation, presumably
via bystander activation caused by proin-
flammatory cytokines, was sufficient to
drive upregulation of costimulatory mole-
cules and induction of T cell proliferation,
whereas this was not the case in the pres-
ent study. This difference may well lie
in the experimental differences: The
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ric mice in which there was a 1:1 mixture
of wild-type DCs and Myd88/ DCs.
Given that TLR-stimulated DCs seem to
be the chief source of IL-12 and other
proinflammatory cytokines, it is possible
ablation of TLR signaling in the vast ma-
jority of DCs compromises both the direct
and indirect pathway of DC activation.
The observations in this study reaffirm
some old truths and reveal new ones.
The paradigm that TLR-mediated activa-
tion of DCs is essential for orchestration
of innate and adaptive responses seems
to be true when soluble TLR ligands are
used. However, it does not seem to hold
true when particulated CpG is used, high-
lighting the fact that redundancy and con-
text recognition are two important facets
of the immune system.
In summary, the invention of Hou et al.
(2008) represents an important tool forIlluminating the Bl
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TNF clearly contributes to immunit
stood. In this issue of Immunity, Cl
the zebrafish-embryo model of tube
The functional complexity of tumor necro-
sis factor (TNF) has provided a formidable
challenge to defining its roles in immunity
and in human health and disease. TNF ex-
erts its action on multiple cell types and
plays a critical but incompletely charac-
terized role in immunity to intracellular
pathogens, including pathogenic myco-
bacteria. TNF contributes to control of
mycobacterial growth in vivo, as well as
to the immunopathology of tuberculosis.
The importance of delineating TNF’s
many roles is underscored by the obser-the dissection of the importance of the
role of TLR signaling in DCs. For example,
this mutant strain should be of great value
in understanding the role of TLRs in DCs in
sensing and tuning immune responses to
pathogens, commensals, and vaccines.
Thus, experiments that evaluate the in-
nate and adaptive responses to microbes,
viruses, commensals, and vaccines will
illuminate the importance of TLR signaling
in DCs in launching protective immunity
versus tolerance. Furthermore, the ques-
tion of what role TLR signaling in DCs
play in modulating the strength, quality,
and longevity of immune responses and
immunological memory is one of great
importance and deserves to be tested.
Thus, the invention of this tool, like the
one invented by our ancestor in 2001:
A Space Odyssey, will have great utility
in exploring deep and fundamental ques-
tions about our immunological universe.ack Box of TNF Ac
anulomas
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y to intracellular pathogens, but how
ay et al. (2008) provide unique insigh
rculosis.
vations that TNF-neutralizing drugs can
promote progression of tuberculosis,
which can be fatal. Although these drugs
have revolutionized treatment of certain
diseases, their infectious complications
can be devastating. A clearer understand-
ing of how drugs that block TNF modulate
immunity to intracellular pathogens may
allow us to devise ways to minimize their
infectious complications and still retain
their anti-inflammatory benefits.
One way that TNF may promote control
of M. tuberculosis is through its effects on
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it does so is incompletely under-
ts, using intravital microscopy and
granulomas. Granulomas consist of orga-
nized aggregates of macrophages (and in
some cases, dendritic cells) that also re-
cruit B and T lymphocytes and provide
a local environment in which immune cells
interact to suppress the pathogen. The
unique organization of granulomas also
serves to prevent widespread inflamma-
tion. Evidence indicates that TNF plays
an essential role in both formation and
maintenance of granulomas, but the
mechanisms of these actions are poorly
understood. In this issue of Immunity,
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